Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2022
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial
Wanpu Yan, Wen-Zhao Zhong, Yan-Hui Liu, et al.
ACS Nano
|
January 25, 2024
Serum Protein Fishing for Machine Learning-Boosted Diagnostic Classification of Small Nodules of Lung
Mengjie Wang, Xin Dai, Xu Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 5, 2023
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
Si-Yang Liu, Qixun Chen, Chengzhi Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 19, 2026
Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial)
Yang Yang, Youhua Jiang, Changchun Wang, et al.
Journal for Immunotherapy of Cancer
|
August 29, 2024
Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study
Tingting Feng, Qian Li, Rui Zhu, et al.
Trials
|
October 11, 2025
Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy
Yumeng Cheng, Yuqin Cao, Shengguang Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 20, 2023
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma
Yang Yang, TingTing Feng, Xiaojun Fan, et al.
Cancer Cell
|
June 21, 2024
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
Qing Zhou, Yi Pan, Xuening Yang, et al.
Signal Transduction and Targeted Therapy
|
June 16, 2026
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial
Yi Pan, Xuening Yang, Qing Zhou, et al.
BMC Cancer
|
June 13, 2022
Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)
Yuqin Cao, Dingpei Han, Su Yang, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2022
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial
Wanpu Yan, Wen-Zhao Zhong, Yan-Hui Liu, et al.
ACS Nano
|
January 25, 2024
Serum Protein Fishing for Machine Learning-Boosted Diagnostic Classification of Small Nodules of Lung
Mengjie Wang, Xin Dai, Xu Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 5, 2023
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
Si-Yang Liu, Qixun Chen, Chengzhi Zhou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 19, 2026
Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial)
Yang Yang, Youhua Jiang, Changchun Wang, et al.
Journal for Immunotherapy of Cancer
|
August 29, 2024
Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study
Tingting Feng, Qian Li, Rui Zhu, et al.
Trials
|
October 11, 2025
Updated protocol of the POINT trial: a multicenter randomized controlled trial investigating effects of preoperative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy
Yumeng Cheng, Yuqin Cao, Shengguang Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 20, 2023
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma
Yang Yang, TingTing Feng, Xiaojun Fan, et al.
Cancer Cell
|
June 21, 2024
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
Qing Zhou, Yi Pan, Xuening Yang, et al.
Signal Transduction and Targeted Therapy
|
June 16, 2026
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial
Yi Pan, Xuening Yang, Qing Zhou, et al.
BMC Cancer
|
June 13, 2022
Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)
Yuqin Cao, Dingpei Han, Su Yang, et al.
Page
of 9